Baring Private Equity Asia (BPEA) and Lumenis announced today that they have entered into a definitive agreement to sell the Lumenis Surgical Business to Boston Scientific in a transaction valued at $1.07 billion, subject to closing adjustments. The Surgical Business includes laser and fibers solutions for minimally invasive surgical procedures in urology and ENT.
Lumenis' high-growth Aesthetics and Vision businesses will continue to operate under BPEA ownership. This strategic sale of the Surgical Business will enable Lumenis to accelerate investment in both domains—in R&D, in global sales and marketing channels, as well as in business development initiatives.
Read more at PR Newswire >>